Found: 106
Select item for more details and to access through your institution.
Creating and evaluating genetic tests predictive of drug response.
- Published in:
- 2008
- By:
- Publication type:
- review
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.
- Published in:
- 2008
- By:
- Publication type:
- Correction Notice
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.
- Published in:
- 2007
- By:
- Publication type:
- journal article
LETTERS.
- Published in:
- 2001
- By:
- Publication type:
- Letter
A modulated empirical Bayes model for identifying topological and temporal estrogen receptor α regulatory networks in breast cancer.
- Published in:
- BMC Systems Biology, 2011, v. 5, n. 1, p. 67, doi. 10.1186/1752-0509-5-67
- By:
- Publication type:
- Article
Morbid obesity and metabolic syndrome in Ossabaw miniature swine are associated with increased platelet reactivity.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2011, v. 4, p. 99, doi. 10.2147/DMSO.S17105
- By:
- Publication type:
- Article
Methadone adverse reaction presenting with large increase in plasma methadone binding: a case series.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Creating incentives for genomic research to improve targeting of therapies.
- Published in:
- Nature Medicine, 2004, v. 10, n. 12, p. 1289, doi. 10.1038/nm1204-1289
- By:
- Publication type:
- Article
2010 Guide to Psychiatric Drug Interactions.
- Published in:
- Primary Psychiatry, 2009, v. 16, n. 12, p. 45
- By:
- Publication type:
- Article
Interacciones farmacológicas y farmacogenómicas en el tratamiento de cáncer de mama y depresión.
- Published in:
- American Journal of Psychiatry - Edición Española, 2009, v. 12, n. 1, p. 11
- By:
- Publication type:
- Article
Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: Implication for optimization of breast cancer treatment<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 1, p. 61, doi. 10.1016/j.clpt.2006.03.013
- By:
- Publication type:
- Article
Drug-metabolizing enzymes: Evidence for clinical utility of pharmacogenomic tests
- Published in:
- 2005
- By:
- Publication type:
- Editorial
Human sympathetic activation by α<sub>2</sub>-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 2, p. 139, doi. 10.1016/j.clpt.2004.04.010
- By:
- Publication type:
- Article
Functional characterization of the 5′-regulatory region of human CYP2C19.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 2, p. P60, doi. 10.1016/S0009-9236(03)90579-0
- By:
- Publication type:
- Article
Relationship of paroxetine disposition to metoprolol metabolic ratio and CYP2D6*10 genotype of Korean subjects<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2000, v. 67, n. 5, p. 567, doi. 10.1067/mcp.2000.106128
- By:
- Publication type:
- Article
Greater quinidine-induced QTc interval prolongation in women<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2000, v. 67, n. 4, p. 413, doi. 10.1067/mcp.2000.105761
- By:
- Publication type:
- Article
Ticlopidine inhibits phenytoin clearance<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1999, v. 66, n. 6, p. 563, doi. 10.1053/cp.1999.v66.103277001
- By:
- Publication type:
- Article
Theophylline pharmacokinetics are not altered by lansoprazole in CYP2C19 poor metabolizers<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 6, p. 606, doi. 10.1016/S0009-9236(99)90082-6
- By:
- Publication type:
- Article
Identification and characterization of human cytchrome P450 (CYP) isoforms interacting with cisapride.
- Published in:
- Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 2, p. 126, doi. 10.1016/S0009-9236(99)80038-1
- By:
- Publication type:
- Article
Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6)<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 1, p. 10, doi. 10.1016/S0009-9236(99)70117-7
- By:
- Publication type:
- Article
Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1998, v. 64, n. 6, p. 597, doi. 10.1016/S0009-9236(98)90050-9
- By:
- Publication type:
- Article
Effect of CYP3A inhibition on vesnarinone metabolism in humans<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1998, v. 63, n. 5, p. 506, doi. 10.1016/S0009-9236(98)90101-1
- By:
- Publication type:
- Article
Ticlopidine inhibition of phenytoin metabolism mediated by potent inhibition of CYP2C19<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1997, v. 62, n. 5, p. 572, doi. 10.1016/S0009-9236(97)90054-0
- By:
- Publication type:
- Article
Determination of CYP2C19 phenotype in black Americans with omeprazole: Correlation with genotype<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 60, n. 2, p. 138, doi. 10.1016/S0009-9236(96)90129-0
- By:
- Publication type:
- Article
S-Mephenytoin hydroxylation phenotypes in a Jordanian population<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1995, v. 58, n. 5, p. 542, doi. 10.1016/0009-9236(95)90174-4
- By:
- Publication type:
- Article
The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: A population study<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1995, v. 57, n. 6, p. 662, doi. 10.1016/0009-9236(95)90229-5
- By:
- Publication type:
- Article
Pharmacogenetic characteristics of the eosinophilia-myalgia syndrome.
- Published in:
- Clinical Pharmacology & Therapeutics, 1994, v. 56, n. 4, p. 398, doi. 10.1038/clpt.1994.154
- By:
- Publication type:
- Article
Enantiomers of naringenin as pleiotropic, stereoselective inhibitors of cytochrome P450 isoforms.
- Published in:
- Chirality, 2011, v. 23, n. 10, p. 891, doi. 10.1002/chir.21005
- By:
- Publication type:
- Article
Stereoselective pharmacokinetics of stable isotope (+/−)-[<sup>13</sup>C]-pantoprazole: Implications for a rapid screening phenotype test of CYP2C19 activity.
- Published in:
- Chirality, 2011, v. 23, n. 10, p. 904, doi. 10.1002/chir.21011
- By:
- Publication type:
- Article
A Model Citizen? Is Tamoxifen More Effective Than Aromatase Inhibitors if We Pick the Right Patients?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 9, p. 610, doi. 10.1093/jnci/djn127
- By:
- Publication type:
- Article
CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 1, p. 30, doi. 10.1093/jnci/dji005
- By:
- Publication type:
- Article
RESPONSE.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Big Data: Challenges and opportunities for clinical pharmacology.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 80, n. 5, p. 1122, doi. 10.1111/bcp.12665
- By:
- Publication type:
- Article
Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 78, n. 2, p. 373, doi. 10.1111/bcp.12348
- By:
- Publication type:
- Article
Editors' report, November 2013.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Effects of clopidogrel and itraconazole on the disposition of efavirenz and its hydroxyl metabolites: exploration of a novel CYP2B6 phenotyping index.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 75, n. 1, p. 244, doi. 10.1111/j.1365-2125.2012.04314.x
- By:
- Publication type:
- Article
In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole L. K. Kamdem et al. Anastrozole metabolism in vitro and in vivo.
- Published in:
- British Journal of Clinical Pharmacology, 2010, v. 70, n. 6, p. 854, doi. 10.1111/j.1365-2125.2010.03791.x
- By:
- Publication type:
- Article
An integrated pharmacokinetics ontology and corpus for text mining.
- Published in:
- BMC Bioinformatics, 2013, v. 14, n. 1, p. 1, doi. 10.1186/1471-2105-14-35
- By:
- Publication type:
- Article
Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 164, n. 2, p. 411, doi. 10.1007/s10549-017-4260-2
- By:
- Publication type:
- Article
Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 161, n. 3, p. 453, doi. 10.1007/s10549-016-4077-4
- By:
- Publication type:
- Article
Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 154, n. 2, p. 263, doi. 10.1007/s10549-015-3608-8
- By:
- Publication type:
- Article
Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 138, n. 3, p. 807, doi. 10.1007/s10549-013-2504-3
- By:
- Publication type:
- Article
The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 133, n. 1, p. 99, doi. 10.1007/s10549-011-1699-4
- By:
- Publication type:
- Article
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 131, n. 3, p. 907, doi. 10.1007/s10549-011-1843-1
- By:
- Publication type:
- Article
Tamoxifen metabolites as active inhibitors of aromatase in the treatment of breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 131, n. 2, p. 473, doi. 10.1007/s10549-011-1428-z
- By:
- Publication type:
- Article
Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 117, n. 3, p. 571, doi. 10.1007/s10549-009-0309-1
- By:
- Publication type:
- Article
Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashes.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 116, n. 3, p. 543, doi. 10.1007/s10549-008-0178-z
- By:
- Publication type:
- Article
Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy.
- Published in:
- 2009
- By:
- Publication type:
- Report